EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATG4B is required for mTORC1 ‐mediated anabolic activity and is associated with clinical outcomes in non‐small cell lung cancer

Patrick J Ryan iD, Bethany C Guerra, Selina Uranga, Jessica M Cardin, Steven E Riechman, Mariana Janini Gomes, James D Fluckey

FEBS Open Bio · 2026

DOI: 10.1002/2211-5463.70138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, 2026. Verfasst von Patrick J Ryan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, College Station, TX, USA. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Autophagy-Related Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complex interplay of metabolic signaling networks is critical to the pathophysiology of lung cancer. The anabolic mTORC1 kinase and catabolic process of autophagy are key among these regulatory pathways. While their relationship has long been viewed as a matter of simple inhibition, with mTORC1 as a negative regulator of autophagy, new evidence suggests that this relationship may be more nuanced than previously described. Here, we demonstrate that an autophagy‐related, ATG4B, is required for mTORC1 activity and is associated with negative clinical outcomes in non‐small cell lung cancer (NSCLC). Targeting ATG4B in vitro suppresses cell proliferation, protein synthesis rates, and mTORC1 signaling in a cellular model of NSCLC. In contrast, overexpressing the ATG4B protease in healthy models of lung tissue increased mTORC1 kinase activity in healthy lung cell models, indicating that an increase in ATG4B is sufficient to drive cellular anabolic signaling. Finally, we found that ATG4B expression is high in NSCLC patient tumors, is elevated in early‐stage cancer, and predicts survival in lung adenocarcinoma patients. Taken together, our results demonstrate that ATG4B is required for anabolic behavior in NSCLC, indicating that the autophagic cascade may be a required input for mTORC1 activity and cellular anabolism in lung cancer. These results have implications for the field of cancer biology more broadly, as they indicate that the far from being a simple target of mTORC1, the autophagic cascade may serve as a requisite input for anabolic signaling, casting new light on the relationship between these processes in cancer pathophysiology. [Correction added on 25 February 2026, after first online publication: 9th sentence has been revised as “Targeting ATG4B in vitro suppresses cell proliferation, protein synthesis rates, and mTORC1 signaling in a cellular model of NSCLC”].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Carcinoma, Non-Small-Cell LungLung NeoplasmsAutophagy-Related ProteinsCysteine EndopeptidasesHumansCell ProliferationAutophagyCell Line, TumorSignal Transduction

Stichwörter der Autor:innen

autophagycell signalingmTORC1metabolismnon‐small cell lung cancer

Substanzen

Mechanistic Target of Rapamycin Complex 1Autophagy-Related ProteinsCysteine EndopeptidasesATG4B protein, human

Autor:innen und Institutionen

  • Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, College Station, TX, USA.

ORCID-Profile: Patrick J Ryan

Förderung

  • Congressionally Directed Medical Research Programs

Zitieren

APA

Ryan, P. J., Guerra, B. C., Uranga, S., Cardin, J. M., Riechman, S. E., Gomes, M. J., & Fluckey, J. D. (2026). ATG4B is required for mTORC1 ‐mediated anabolic activity and is associated with clinical outcomes in non‐small cell lung cancer. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70138

Vancouver

Ryan PJ, Guerra BC, Uranga S, Cardin JM, Riechman SE, Gomes MJ, et al. ATG4B is required for mTORC1 ‐mediated anabolic activity and is associated with clinical outcomes in non‐small cell lung cancer. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70138

BibTeX
@article{Ryan2026,
  author = {Ryan, Patrick J and Guerra, Bethany C and Uranga, Selina and Cardin, Jessica M and Riechman, Steven E and Gomes, Mariana Janini and Fluckey, James D},
  title = {ATG4B is required for mTORC1 ‐mediated anabolic activity and is associated with clinical outcomes in non‐small cell lung cancer},
  journal = {FEBS Open Bio},
  year = {2026},
  doi = {10.1002/2211-5463.70138}
}
Kostenlos starten →